In This Article:
Over the last 7 days, the United States market has dropped 3.7%, yet it remains up by 6.9% over the past year with earnings forecasted to grow by 14% annually. In this context of fluctuating performance, identifying high growth tech stocks that can potentially capitalize on these trends involves looking for companies with strong innovation capabilities and robust financial health.
Top 10 High Growth Tech Companies In The United States
| Name | Revenue Growth | Earnings Growth | Growth Rating |
|---|---|---|---|
| TG Therapeutics | 26.19% | 37.78% | ★★★★★★ |
| Alkami Technology | 21.98% | 85.17% | ★★★★★★ |
| Travere Therapeutics | 28.43% | 65.01% | ★★★★★★ |
| AVITA Medical | 27.78% | 55.33% | ★★★★★★ |
| Clene | 61.16% | 59.11% | ★★★★★★ |
| Alnylam Pharmaceuticals | 22.82% | 58.64% | ★★★★★★ |
| Blueprint Medicines | 22.38% | 55.75% | ★★★★★★ |
| Applied Optoelectronics | 58.93% | 141.15% | ★★★★★★ |
| TKO Group Holdings | 21.90% | 25.17% | ★★★★★★ |
| Lumentum Holdings | 21.55% | 119.67% | ★★★★★★ |
Click here to see the full list of 240 stocks from our US High Growth Tech and AI Stocks screener.
Here we highlight a subset of our preferred stocks from the screener.
Bit Digital
Simply Wall St Growth Rating: ★★★★★☆
Overview: Bit Digital, Inc. is involved in the bitcoin mining industry with a market capitalization of approximately $318.95 million.
Operations: Bit Digital, Inc. generates revenue primarily through its involvement in the bitcoin mining sector, with a notable contribution from software and programming amounting to $98 million.
Bit Digital's strategic advancements are evident with a projected annual revenue growth of 44.4% and an anticipated profit surge of 108% per year, positioning it well above the average market trajectory. Recent collaborations, such as the extended partnership with Soluna Holdings for enhanced mining operations and a significant colocation contract with a leading AI hardware innovator through WhiteFiber, underscore its expanding influence in high-performance computing (HPC) and AI sectors. These moves not only broaden Bit Digital's service capabilities but also solidify its footprint in critical tech domains, promising robust future prospects despite current unprofitability and shareholder dilution concerns.
-
Navigate through the intricacies of Bit Digital with our comprehensive health report here.
-
Review our historical performance report to gain insights into Bit Digital's's past performance.
Alvotech
Simply Wall St Growth Rating: ★★★★★★
Overview: Alvotech, with a market cap of $3.23 billion, develops and manufactures biosimilar medicines globally through its subsidiaries.
Operations: With a revenue stream of $393.92 million from its biotechnology segment, Alvotech focuses on the development and manufacturing of biosimilar medicines for a global market.